VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma

NCT00111319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib

Sponsor

Millennium Pharmaceuticals, Inc.

Collaborators

[object Object]